SCHEMBL9946971

SCHEMBL9946971

CCc1cc(NCC(F)F)c(C(=O)Nc2ccc(F)c(Cl)c2)cc1N

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 1/20 0.53
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
PTGES O14684 1/20 0.50
SMN1; SMN2 Q16637 5/20 0.47
TSHR P16473 2/20 0.46
LMNA P02545 1/20 0.45
EGFR P00533 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9946577 0.88 FADS1 (0.53) FADS1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9946968 0.79 PTGES (0.53) FADS1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9944835 0.78 FADS1 (0.56) FADS1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL10170901 0.72 FADS1 (0.63) FADS1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL10170839 0.72 FADS1 (0.51) FADS1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9899451 0.71 FADS1 (0.50) FADS1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL11992718 0.70 EGFR (0.57) FADS1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9944731 0.69 FADS1 (0.53) FADS1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL24460129 0.68 HDAC3 (0.60) FADS1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1671470 0.67 FADS1 (0.53) FADS1CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012076673-A1 6-AMINO-2-PHENYLAMINO-1H-BENZIMIDAZOLE-5-CARBOXAMIDE- DERIVATIVES AND THEIR USE AS MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 WO disclosed